USA - NASDAQ:MPB - US59540G1076 - Common Stock
| TTM (2025-9-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 211.34M | 179.16M | 166.98M | 171.50M | 130.10M | |||
| Gross Premiums Earned | null | null | null | null | null | |||
| Loss Claims | null | null | null | null | null | |||
| Deferred Policy Acquisition Expense | null | null | null | null | null | |||
| Net Interest Income | 185.62M | 156.67M | 146.97M | 147.80M | 108.60M | |||
| Non Interest Income | 25.71M | 22.49M | 20.01M | 23.70M | 21.50M | |||
| Loan Loss Provision | 2.47M | 1.52M | 3.29M | 4.30M | null | |||
| Net Interest Income after Provision | 183.16M | 155.16M | 143.68M | 143.50M | 108.60M | |||
| Non Interest Expense | -147.34M | -117.62M | -118.99M | -99.80M | -94.10M | |||
| Minority Interest Expense | null | null | null | null | null | |||
| Cost Of Goods | null | null | null | null | null | |||
| Gross Profit | null | null | null | null | null | |||
| Operating Expenses | null | null | null | null | null | |||
| Research and Development | null | null | null | null | null | |||
| Selling, General, and Administrative Expenses | null | null | null | null | null | |||
| Operating Income | null | null | null | null | null | |||
| Interest Income/Expense | null | null | null | null | null | |||
| Other Income/Expense | null | null | null | null | null | |||
| Non Recurring Items | null | null | null | null | null | |||
| Income Before Taxes | 61.53M | 60.03M | 44.69M | 67.30M | 36.10M | |||
| Income Tax | 11.50M | 10.60M | 7.30M | 12.50M | 6.70M | |||
| Net Income | 50.03M | 49.44M | 37.40M | 54.80M | 29.30M | |||
| EBITDA | null | undefined | undefined | undefined | undefined | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | 2.4372 | 2.896 | 2.2871 | 3.44 | 2.71 | |||
| Non GAAP EPS | 2.54 | 2.9 | 2.67 | 3.44 | 2.98 | |||
| Statistics | ||||||||
| Profit Margin | 23.67% | 27.59% | 22.40% | 31.95% | 22.52% | |||
All data in USD